Drug Patent Expirations for Mar 17, 2016

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. FLO-PRED (prednisolone acetate) Taro Patent number: 5,881,926 Expiration Date: Mar 16, 2016 DrugPatentWatch provides instant access to actionable insights on pharmaceutical drugs. For more information try […]



Which pharma companies have the most ‘New Dosage Form’ exclusivities?

New Dosage Forms are one of the categories for which the FDA grants three years of exclusivity for ‘New Clinical Investigations.’ Alternate categories worth of three years of protection include identifying a New Patient Population, New Product, or New Strength. This chart shows the companies which have received the most New Dosage Form exclusivities in […]



Drug Patent Expirations for Mar 10, 2016

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. METVIXIA (methyl aminolevulinate hydrochloride) Galderma Labs Lp Patent number: 6,034,267 Expiration Date: Mar 8, 2016 SUMAVEL DOSEPRO (sumatriptan succinate) Endo Ventures Ltd Patent number: 5,957,886 Expiration […]



Drug Patent Expirations for Mar 3, 2016

DrugPatentWatch provides competitive intelligence on small-molecule drugs and the 90,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. LUXIQ (betamethasone valerate) Delcor Asset Patent number: 6,126,920 Expiration Date: Mar 1, 2016 FAMVIR (famciclovir) Novartis Patent number: 5,916,893 Expiration Date: Mar 1, 2016 ZELAPAR (selegiline hydrochloride) Valeant […]



Bioentrepreneurship education programmes in the United States

This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Bioentrepreneurship education programmes in the United States
Go to paperABSTRACT: In this first paper of a new regular column, Arlen Meyers and Patrick…



Drug Patent Expirations for Feb 4, 2016

DrugPatentWatch provides competitive intelligence on small-molecule drugs and the 90,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. ELOXATIN (oxaliplatin) Sanofi Aventis Us Patent number: 5,716,988 Expiration Date: Feb 7, 2016 For more information try a free trial



Drug Patent Expirations for Jan 28, 2016

DrugPatentWatch provides competitive intelligence on small-molecule drugs and the 90,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. NUEDEXTA (dextromethorphan hydrobromide; quinidine sulfate) Avanir Pharms Patent number: RE 38,115 Expiration Date: Jan 26, 2016 UTIBRON (glycopyrrolate ; indacaterol maleate) Novartis Pharms Corp Patent number: 6,521,260 Expiration […]



Make in India — nowhere to go but up

Make in India recently published an advertorial in the Washington Post proclaiming that “2016 is India’s Growth Year For Pharma.” I don’t doubt that India has growth potential, as it ranks 51st out of 54 nations that I compare in the Scientific American Worldview scorecard. The problem with Make in India’s encouraging proclamation is that […]